share_log

Janux Therapeutics | 8-K: Janux Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights

SEC ·  May 9, 2024 03:42
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more